Catalyst Wire Dossier Catalyst Wire Dossier

Pritumumab

pritumumab · Nascent Biotech
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pritumumab, covering 2024-12-06 to 2024-12-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Pritumumab in Brain Cancer [Phase 1]

See pricing